The FDA unveiled a new strategy to tackle the ongoing shortage of ADHD medications that includes streamlining the approval process for new manufacturing facilities and increasing production limits for existing manufacturers, The New York Times reported Sept. 6.
The Latest
Orange County, Calif., will terminate its contract with nonprofit mental health provider Be Well after an audit found systemic failures, Voice of OC reported Sept. 9.
The Agency for Healthcare Research and Quality will put millions toward studying patient-centered outcomes in behavioral health.
The Biden Administration has finalized rules requiring insurers to cover mental healthcare at the same level as other health services.
The number of middle and high school students using e-cigarettes dropped to the lowest level in a decade, according to new data from the FDA.
Judges have appointed permanent receivers to oversee the sale of Retreat Behavioral Health's clinics in Florida, Pennsylvania and Connecticut, LancasterOnline reported Sept. 5.
Digital health companies are turning their attention to mental health solutions for young people.
Twenty-two percent of people who died of drug overdoses in 2022 had non-substance use related mental health disorders, according to an Aug. 29 analysis by HHS' Morbidity and Mortality Weekly Report.
Spokane, Wash.-based Sacred Heart nurses, technicians, service and maintenance workers are planning to rally in protest of the hospital's plans to permanently close the inpatient child psychiatric unit, KXLY.com reported Sept. 4.
The Drug Enforcement Administration has increased the production limit of Vyvanse, an ADHD drug made by Takeda Pharmaceutical, and its generic versions by 24% to address an ongoing shortage of the medicines in the U.S.